HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Speaker at Drug Delivery Events - Vladlen Slepak
Keynote Presentation (In-Person)
Vladlen Slepak, University of Miami Miller School of Medicine, United States

Over 30% of pharmaceuticals act on G protein-coupled receptors (GPCRs), the largest family of human genes (~800).  About 50% of GPCRs (~400) are Olfactory receptors (ORs); these GPCRs were originally discovered in the nasal epithelium, where they mediate the sense of smell. [....] » Read More

Speaker at Drug Delivery Events -  Andreas M Papas
Keynote Presentation (In-Person)
Andreas M Papas, Antares Health Products, United States

Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glyco [....] » Read More

Speaker at Drug Delivery Events - Sergey Suchkov
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and systems biology-related processes specific to a particular patient (ignoring persons-at-risk). A new systems approach to [....] » Read More

Speaker at Drug Delivery Events - Miroslav Radenkovic
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary arterial hypertension (PAH) remains a devastating disease with high morbidity and mortality. It is uncommon, progressive and life-threatening blood vessel disorder differentiated by the constriction of minor pulmonary arteries and elevated blood pressure in the pulmonar [....] » Read More

Speaker at Pharmaceutical Conference - Consolato M Sergi
Keynote Presentation (Virtual)
Consolato M Sergi, Universities of Alberta and Ottawa, Canada

Introduction: Metabolic-(non-alcoholic) associated fatty liver disease (MAFLD/NAFLD) has increasingly become a worldwide epidemic. It has been suggested that renaming NAFLD to MAFLD is critical in identifying patients with advanced fibrosis and poor cardiovascular outcomes. There [....] » Read More

Speaker at Pharma Conferences - Paulo Cesar De Morais
Keynote Presentation (Virtual)
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil

In this keynote talk, the traditional disc diffusion-test bioassay is revisited within the perspective of using a mathematical approach grounded on the standard as well as on the modified Hill model. Importantly, the Hill model was established in 1910 to account for the binding o [....] » Read More

Speaker at Drug Delivery Events - Sergey Suchkov
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

A new systems approach to subclinical, predictive and/or diseased states and wellness resulted in a new Hi Tech trend in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, despite breakthroughs in designed-driven research that have led to an in [....] » Read More

Speaker at Drug Delivery Events - Sergey Suchkov
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

The identification, impact and implementation of diagnostic, predictive and prognostic biomarkers of the next step generation becomes the Holy Grail of platforms, algorithms and protocols, which are the crucial for Personalized & Precision Medicine (PPM). High impact of Ab-pr [....] » Read More

Speaker at Pharmaceutical Conference - Srividya Narayanan
Oral Presentation (In-Person)
Srividya Narayanan, Northeastern University, United States

Nanotechnology has revolutionized pharmaceutical and biomedical applications, offering a plethora of opportunities in drug delivery, medical imaging, and cancer therapy. However, the unique properties of nanomaterials present significant regulatory challenges that must be address [....] » Read More

Speaker at Drug Delivery Events - Aarti V Belgamwar
Oral Presentation (In-Person)
Aarti V Belgamwar, Shri Vile Parle Kelvani Mandal’s Institute of Pharmacy, India

Although successful strides have been made in the HIV-1 response, ending AIDS threat by 2030 is a significant challenge, as HIV-1 infections among adolescents and young adult have not decreased fast enough to curb the epidemic. Globally, of the estimated 39.0 million people livin [....] » Read More

Speaker at Pharmaceutical Conference - Eman Shalaby
Oral Presentation (In-Person)
Eman Shalaby, National Research Centre, Egypt

Photoaging is one of the most common issues in the world, affecting nearly all women. The term "photoaging" describes the early aging of skin brought on by excessive exposure to ultraviolet radiation. Our study's objective was to evaluate Allantoin proposomes' a [....] » Read More

Speaker at Drug Delivery Events - Hashem M Mansour
Oral Presentation (In-Person)
Hashem M Mansour, Indonesian Hospital, State of Palestine

Background: In this study, we analysed the data on antimicrobial resistance in the bloodstream. This study aims to evaluate the bacterial resistance in the Gaza Strip and compare with that in other countries. Methods: This study was conducted retrospectively in the Indonesian [....] » Read More

Speaker at Drug Delivery Events - Haitham A Saleh
Poster Presentation (In-Person)
Haitham A Saleh, Qatar University, Qatar

Diabetes mellitus is a chronic disease characterized by metabolic defects, including insulin deficiency and resistance. Individuals with diabetes are at increased risk of developing cardiovascular complications, such as atherosclerosis, coronary artery disease, and hypertension. [....] » Read More

Speaker at Pharma Conferences - Luis Jesus Villarreal Gomez
Keynote Presentation (Virtual)
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico

This research explores the creation of a novel exosome delivery platform, termed Exo-ITC, tailored for use in dermatology. Exosomes, as extracellular vesicles, are pivotal in intercellular communication and exhibit substantial therapeutic potential in regenerative medicine and de [....] » Read More

Speaker at Pharma Conferences - Saad Tayyab
Keynote Presentation (Virtual)
Saad Tayyab, UCSI University, Malaysia

Understanding drug transport in plasma is pivotal to optimizing therapeutic outcomes, as it governs drug distribution, efficacy, and clearance. A key factor in this process is protein binding, where drugs reversibly interact with plasma proteins such as albumin and alpha-1-acid g [....] » Read More

Speaker at Pharma Conferences - Gurpreet Singh
Oral Presentation (Virtual)
Gurpreet Singh, IQVIA, United Kingdom

The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical Companies based on projected R&D spending in 2026 are Roche, Johnson & Johnson, Merck & [....] » Read More

Speaker at Pharmaceutical Conference - Dharmendra Kumar
Oral Presentation (Virtual)
Dharmendra Kumar, Sanskaram University, India

One of the primary challenges in pharmaceutical dosage form development is the poor solubility of certain drugs, particularly those classified as Biopharmaceutics Classification System (BCS) Class IV. These drugs exhibit low solubility and permeability, resulting in suboptimal ph [....] » Read More

Speaker at Pharma Conferences - Prashant Bhokardankar
Oral Presentation (Virtual)
Prashant Bhokardankar, Datta Meghe Ayurved College, India

Mineral and metallic nanomedicines are a precious resource found in the Ayurvedic medical system. Rasashastra is an Ayurvedic branch that deals with the preparation and therapeutic use of nanomedicines. A weak interdisciplinary collaboration between science and Ayurveda ultimatel [....] » Read More

Speaker at Pharma Conferences - Nilay Solanki
Oral Presentation (Virtual)
Nilay Solanki, CHARUSAT Campus, India

Background: Neurodegenerative diseases, such as Alzheimer’s disease (AD), are marked by the accumulation of proteins with altered physicochemical properties in the brain and other tissues, leading to progressive neuronal decline. This study explores the therapeutic potentia [....] » Read More

Speaker at Pharma Conferences - Nilay Solanki
Oral Presentation (Virtual)
Nilay Solanki, CHARUSAT Campus, India

Doxorubicin (DXR) is a powerful chemotherapeutic drug commonly used to treat cancers such as breast cancer, bladder cancer, Kaposi's sarcoma, and lymphoma. However, its clinical use is often limited by severe side effects, including cardiomyopathy, bone marrow suppression, an [....] » Read More

Scientific Programs coming soon..

Watsapp